Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Shenzhen Hepalink Pharmaceutical Group HK$4.05 billion IPO
Davis Polk advised Shenzhen Hepalink Pharmaceutical Group Co., Ltd. in connection with its initial public offering and…
Oryzon Genomics €20 million private placement
Davis Polk advised Oryzon Genomics, S.A. on its private placement of approximately 7,273,000 of its ordinary shares pursuant…
1Life Healthcare $296 million secondary offering
Davis Polk advised the representatives of the several underwriters in connection with the $296 million SEC-registered…
Magenta Therapeutics $69 million follow-on offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $69…
Editas Medicine $215.6 million stock offering
Davis Polk advised the sole book-running manager in connection with the $215.6 million common stock offering of 6,900…
Abbott Laboratories $1.3 billion notes offering
Davis Polk advised the joint book-running managers on an SEC-registered offering by Abbott Laboratories of $650 million…
Acadia Healthcare $450 million high-yield notes offering
Davis Polk advised the representative of the initial purchasers of a Rule 144A/Regulation S offering by Acadia Healthcare…
Merck $4.5 billion notes offering
Davis Polk advised the representatives of the underwriters, in connection with the offering of $4.5 billion aggregate…
CryoLife $100 million convertible senior notes offering
Davis Polk advised the initial purchaser in connection with a Rule 144A offering by CryoLife, Inc. of $100 million aggregate…
Genetron Holdings $256 million IPO
Davis Polk advised Genetron Holdings Limited on its SEC-registered initial public offering of 16,000,000 American Depositary…